Amgen

What Investors Think About Amgen
Motley Fool
Mon, 06/14/10 - 02:49 pm
Amgen
investors
ASCO Pops and Drops
Motley Fool
Wed, 06/9/10 - 04:47 pm
ASCO
Keryx
Ziopharm
Bristol-Myers Squibb
Pfizer
Celgene
Novartis
Amgen
Amgen at ASCO: Surprise! There's More to Its Story than Prolia
BNET Pharma
Wed, 06/9/10 - 08:12 am
Amgen
ASCO
Prolia
pancreatic cancer
ovarian cancer
pipelines
Amgen Back in the Spotlight
Seeking Alpha
Tue, 06/8/10 - 08:51 am
Amgen
Prolia
prostate cancer
osteoporosis
Good News for Big Pharma at ASCO
Yahoo/Indie Research
Mon, 06/7/10 - 08:43 am
ACSCO
Big Pharma
Baxter International
Bristol-Myers Squibb
Amgen
Eli Lilly
Pfizer
Amgen's Hopes for Prolia Go Beyond Osteoporosis Therapy
Seeking Alpha
Sun, 06/6/10 - 10:57 am
Amgen
Prolia
osteoporosis
Bone metastases
New AMG 386 Data Demonstrate Promising Antitumor Activity in Patients With Recurrent Ovarian Cancer
Yahoo/PR NewsWire
Sun, 06/6/10 - 10:54 am
Amgen
AMG 386
paclitaxel
ovarian cancer
Amgen Gets FDA Approval and SonoSite Has a New Frontier
Motley Fool
Sat, 06/5/10 - 09:50 am
Amgen
denosumab
Prolia
SonoSite
ultrasound
Amgen's New Osteoporosis Drug: It May Not Fly Under Healthcare Reform
BNET Pharma
Thu, 06/3/10 - 08:55 pm
Amgen
osteoporosis
Prolia
healthcare reform
Amgen Likely to React Dramatically to Early FDA Approval of Osteoporosis Drug
Seeking Alpha
Wed, 06/2/10 - 08:22 am
Amgen
Prolia
osteoporosis
FDA
FDA clears Amgen's bone-strengthening drug, Prolia
Yahoo/AP
Wed, 06/2/10 - 08:21 am
FDA
Prolia
Amgen
GSK
Merck
Zemeta
Fosamax
osteoporosis
Amgen ready to extend global reach
FT.com
Tue, 06/1/10 - 05:50 am
Amgen
M&A
Prolia
Europe
EU Approval for Amgen's Prolia
Yahoo/Zacks
Sat, 05/29/10 - 09:28 am
Amgen
Prolia
prostate cancer
osteoporosis
Zacks Analyst Blog Highlights: Amgen Inc., Novartis, Merck, GlaxoSmithKline and Eli Lilly
Yahoo/Zacks.com
Mon, 05/24/10 - 07:56 am
Amgen
Merck
Eli Lilly
GSK
Novartis
Amgen Highlights Key Clinical Data to Be Presented at American Society of Clinical Oncology Annual Meeting
PR-USA
Sun, 05/23/10 - 12:07 pm
Amgen
denosumab
zoledronic acid
Bone metastases
prostate cancer
Amgen’s Crop of Experimental Cancer Drugs Shows Initial Results
Bloomberg
Fri, 05/21/10 - 10:47 am
Amgen
cancer
pancreatic cancer
ovarian cancer
pipelines
denosumab
Amgen Cancer Drugs Slow March of Deadly Tumors, Studies Suggest
Bloomberg
Thu, 05/20/10 - 06:29 pm
Amgen
cancer
pancreatic cancer
ovarian cancer
conatumumab
Biosimilars Aren't So Darn Easy
Seeking Alpha
Wed, 05/19/10 - 10:36 am
biosimilars
Merck
Amgen
Health-Care Reform Hits Drugmakers' (and Your) Pockets
Motley Fool
Tue, 05/18/10 - 09:31 pm
healthcare reform
Eli Lilly
Biogen Idec
Gilead Sciences
Abbott Laboratories
Amgen
Bristol-Myers Squibb
Pfizer
Merck
Amgen (AMGN) Submits BLA to U.S. FDA for Denosumab RANK Inhibitor
Street Insider
Mon, 05/17/10 - 10:36 am
Amgen
BLA
FDA
denosumab
RANK Ligand inhibitor

Pages